BIOTECHNOLOGY SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain Medical Device News MagazineFebruary 7, 2024February 7, 20240 SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain. Read More